Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Flores YN, Datta GD, Yang L et al (2021) Disparities in hepatocellular carcinoma incidence, stage, and survival: a large population-based study. Cancer Epidemiol Biomarkers Prev 30(6):1193–1199
2. Konyn P, Ahmed A, Kim D (2021) Current epidemiology in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol 15(11):1295–1307
3. Benson AB, D'Angelica MI, Abbott DE et al (2021) Hepatobiliary cancers, version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 19(5):541–565
4. Reig M, Forner A, Avila MA et al (2021) Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH. Med Clin (Barc) 156(9):463 e461–463 e430
5. Zhou WP, Lai EC, Li AJ et al (2009) A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 249(2):195–202
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献